CHEMOMAB THERAPEUTICS LTD (CMMB)       2.5  +0.01 (+0.4%)

2.5  +0.01 (+0.4%)

US16385C1045 - ADR

Buy % Consensus

Analysts have set a mean price target of 21.42. This target is 756.8% above the current price.
CMMB was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about CMMB.
In the previous month the buy percentage consensus was at a similar level.
CMMB was analyzed by 9 analysts. More opinions would make the average more meaningful.

Price Target

Price Low Median Mean High 2.5017.1721.4221.4226.25 - 586.80% 756.80% 756.80% 950.00%

Up and Down Grades

Date Firm Action Rating
2022-03-10 Oppenheimer Maintains Outperform
2021-12-07 Aegis Capital Initiate Buy
2021-05-26 Cantor Fitzgerald Initiate Overweight
2021-05-07 Oppenheimer Initiate Outperform

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA